title: Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
abstract: In vitro data have shown that the hepatitis C virus (HCV) core protein binds to protein members of the tumour necrosis factor receptor (TNFR) superfamily. Since this interaction could be relevant to HCV persistence and oncogenesis, this study assessed whether HCV may interfere with the apoptotic cascade in vivo. Apoptosis (by TUNEL) and Fas and TNFR1 expression (by immunohistochemistry) were scored in the liver of 60 chronic hepatitis C patients. Results were compared with the liver disease grading and staging scores and the HCV replication level in serum and liver. Apoptotic hepatocytes were stained in 29 cases. Fas was expressed in 35 cases and TNFR1 in 21, 15 patients (25%) being negative for both receptors. Overall, the numbers of TUNEL-, Fas- and TNFR-positive hepatocytes did not correlate with the extent of intrahepatic CD8+ T-lymphocyte infiltration, the grading and staging of liver disease, or the serum or liver HCV RNA levels. Furthermore, when patients expressing either Fas or TNFR1 were stratified according to serum HCV RNA levels, cases with detectable hepatocyte apoptosis had higher HCV viraemias. In conclusion, an HCV-mediated, in vivo blockade of hepatocyte apoptosis via the Fas- or TNFR1-dependent pathways seems unlikely.
authors.affiliation: Division of Clinical Pathology, University Hospital, 1211 Geneva, Switzerland.
authors.forename: Laura
authors.initials: L
authors.lastname: Rubbia-Brandt
authors.forename: Sophia
authors.initials: S
authors.lastname: Taylor
authors.forename: Patrizia
authors.initials: P
authors.lastname: Gindre
authors.forename: Rafael
authors.initials: R
authors.lastname: Quadri
authors.forename: Karim
authors.initials: K
authors.lastname: Abid
authors.forename: Laurent
authors.initials: L
authors.lastname: Spahr
authors.forename: Francesco
authors.initials: F
authors.lastname: Negro
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D017209:Apoptosis; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000276:immunology / Q000473:pathology*; D022781:Hepatocytes / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D020287:In Situ Nick-End Labeling; D008099:Liver / Q000276:immunology / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D047888:Receptors, Tumor Necrosis Factor, Type I; D014779:Virus Replication; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D015703:Antigens, CD; D012367:RNA, Viral; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D019014:fas Receptor